Novartis AG (NVS) Fair Value & DCF
Score
NVS fair value $250.38. Price $160.20. Price is 36% below fair value.
Worked example
Cash-flow value. Starting free cash flow is $7.86 a share. Year 1 is the first earnings forecast, so it has no growth rate of its own. The forecast then reaches 6.84%, and that pace fades in a straight line to 3% terminal growth by year 10. The discount rate is 8.70% (beta 0.80). It is beta-adjusted and capped at 12%. The cash-flow value is $233.75 a share.
Earnings value. Next-twelve-months earnings per share of $9.80 times 27.26 is $267.02. The peer group is Drug Manufacturers - General, 8 companies worth at least $10 billion. Peer median 34.3. Own 10-year median 20.2. The multiple used is the average of the two, kept between 8 and 30, which is 27.26.
Fair value is the average of the two, $250.38. The price is $160.20, which is 36.0% below fair value.